New York Assembly Bill A08090

New York 2025-2026 Regular Session

• Introduced: 4/25/25
• Refer: 4/25/25
• Report Pass: 5/6/25
• Refer: 5/6/25
• Report Pass: 5/27/25
• Refer: 5/27/25
• Report Pass: 5/29/25
• Engrossed: 5/29/25
• Refer: 5/29/25
• Engrossed: 6/12/25
• Enrolled: 12/1/25
• Vetoed: 12/5/25

Caption

Requires the commissioner of health to produce a report on the utilization and activity of the elderly pharmaceutical insurance coverage program, including future enrollment and program cost projections, and to publish such report and deliver the report to the governor, the temporary president of the senate, and the speaker of the assembly.

Impact

Should A08090 be enacted, it would have significant implications for the understanding of the elderly pharmaceutical insurance program at both administrative and community levels. The requirement for a formalized report would allow for a clearer insight into the enrollment trends and the economic impact of the program on elderly individuals, potentially leading to necessary adjustments in funding or resource allocation. By emphasizing statistical reporting, the bill aims to ensure that both state officials and the public are well-informed about the performance of this crucial program.

Summary

Bill A08090 seeks to amend the elder law by requiring the commissioner of health to generate a report concerning the elderly pharmaceutical insurance coverage program. The report is mandated to include statistical information about enrollment demographics, such as marital status, income levels, and age for each program year spanning from 2022 to 2026. Furthermore, it will touch upon various aspects of the program such as subsidies under federal guidelines and the distribution of pharmacy claims. Aimed at enhancing transparency and oversight, the bill endeavors to provide a comprehensive evaluation of the program's performance and effectiveness.

Contention

Notably, the bill could serve as a point of contention regarding issues of efficiency and government oversight. Some may argue that such reports could delay necessary legislative decisions or create bureaucratic bottlenecks. Additionally, there might be debates about data privacy concerning the collection and reporting of sensitive information about enrollees, especially regarding income levels and health-related status. Overall, while the bill is designed to foster accountability, it may also spark discussions about the balance between transparency and privacy.